FMC Corporation announces fourth quarter and full-year 2023 results within guidance ranges, provides 2024 outlook
- Consolidated GAAP net income increased by 291% versus Q4 2022
- Full-year 2023 revenue reflected a year-over-year decline of 23%
- The company reported negative cash flow from operations and free cash flow in 2023
- The outlook for full-year 2024 includes a forecasted revenue of $4.50 to $4.70 billion, reflecting 2.5% growth at the midpoint
- Revenue decreased by 29% in Q4 2023 versus Q4 2022
- Adjusted EBITDA decreased by 41% in Q4 2023 versus Q4 2022
- The company reported a negative cash flow from operations and free cash flow in 2023
Insights
The reported decline in revenue and organic sales, juxtaposed with the significant increase in GAAP net income and earnings per share (EPS), indicates a complex financial situation for FMC Corporation. The substantial rise in GAAP net income is attributed to one-time tax benefits, which are non-recurring and do not necessarily reflect operational performance. The decrease in revenue and organic sales is concerning as it suggests a reduction in demand and potential market challenges, such as the mentioned destocking and adverse weather conditions.
Looking ahead, the forecast for 2024 indicates only a slight increase in revenue and essentially flat adjusted EBITDA, with the company's performance heavily reliant on the successful introduction and scaling of new products. The expected improvement in free cash flow is a positive sign, indicating better cash management and potential recovery from the previous year's negative cash flow. However, investors should consider the volatility of market conditions and the company's ability to execute its restructuring plan effectively.
The focus on new product introductions (NPI) and branded diamides highlights FMC's strategic emphasis on innovation and differentiation in the crop protection market. The fact that NPI sales comprised 14 percent of total revenue in Q4 and branded diamides saw a 5 percent growth in a declining market is indicative of a competitive advantage. However, the overall market contraction and destocking activities suggest a cautious approach from distributors and end-users, which may reflect broader agricultural sector trends or economic factors affecting purchasing behavior.
The resilience of FMC's differentiated products, despite a broader downturn, is a positive signal for the company's R&D and marketing strategies. Still, the company's performance will likely be influenced by external factors such as weather patterns, crop prices and global economic conditions that affect agricultural input demand.
The negative cash flow and decline in adjusted EBITDA reflect operational challenges that FMC faced in 2023, which are concerning from an economic standpoint. These figures suggest that the company's cost-saving measures and pricing strategies were not sufficient to fully offset the decline in sales volume. The negative free cash flow is particularly alarming as it can impact a company's ability to invest in growth, pay dividends, or reduce debt.
For 2024, the company's outlook suggests modest growth expectations, potentially reflecting an anticipation of continued economic headwinds or market saturation. The reliance on restructuring benefits and new product sales to drive future performance indicates that FMC is in a transitional phase, attempting to adapt to shifting market dynamics. Investors should monitor the company's ability to manage costs and innovate in response to these challenges.
New products and branded diamides delivered strong results despite continued destocking.
Fourth Quarter 2023 Highlights
- Revenue of
, a decrease of 29 percent versus Q4 2022 and down 30 percent organically1$1.15 billion - Consolidated GAAP net income of
, up 291 percent versus Q4 2022$1.10 billion - Adjusted EBITDA of
, down 41 percent versus Q4 2022$254 million - Consolidated GAAP earnings of
per diluted share, up 304 percent versus Q4 2022$8.77 - Adjusted earnings of
per diluted share, down 55 percent versus Q4 2022$1.07 - 14 percent of sales in the quarter from new product introductions (NPI)
Full-Year 2023 Highlights
- Revenue of
, reflecting a year-over-year decline of 23 percent and down 22 percent organically1$4.49 billion - Consolidated GAAP net income of
, up 78 percent versus 2022$1.32 billion - Adjusted EBITDA of
, down 30 percent versus 2022$978 million - Consolidated GAAP earnings of
per diluted share, up 81 percent versus 2022$10.53 - Adjusted earnings of
per diluted share, down 49 percent versus 2022$3.78 - Consolidated GAAP cash flow from operations of negative
, down 145 percent versus 2022$300 million - Free cash flow of negative
, down 202 percent versus 2022$524 million - NPI sales of
represented annual record 13 percent of total revenue$590 million
Full-Year 2024 Outlook2
- Revenue of
to$4.50 , reflecting 2.5 percent growth at the midpoint$4.70 billion - Adjusted EBITDA of
to$900 million , essentially flat to prior year at the midpoint$1.05 billion - Restructuring fully underway and expect to receive
to$50 of adjusted EBITDA benefit$75 million - Adjusted earnings per diluted share of
to$3.23 , reflecting 1 percent growth at the midpoint$4.41 - Free cash flow is expected to be in the range of
to$400 , reflecting greater than 100 percent cash flow conversion at the midpoint$600 million
FMC Corporation (NYSE: FMC) today reported fourth quarter 2023 revenue of
Fourth Quarter Adjusted EPS versus Guidance (midpoint)* | |
Adjusted EBITDA | -15 cents |
Depreciation and amortization | |
Interest expense | |
Taxes | |
Minority interest | |
Share count | |
* Guidance refers to midpoint of EPS guidance presented in October 2023 |
"During the fourth quarter we observed continued channel destocking in all regions, while drought in
FMC revenue in the fourth quarter was driven by a 25 percent decline from volume. A 5 percent decline in pricing was partially offset by a 1 percent FX tailwind. Sales of products launched in the last five years comprised 14 percent of total revenue in the quarter.
Sales in
FMC Revenue | Q4 2023 | Full Year 2023 | |||||||||
Total Revenue Change (GAAP) | (29 %) | (23 %) | |||||||||
Less FX Impact | 1 % | (1 %) | |||||||||
Organic1 Revenue Change (Non-GAAP) | (30 %) | (22 %) |
Fourth quarter adjusted EBITDA was
For the full year, FMC reported revenue of
"Despite challenging market conditions in 2023, we maintained very healthy adjusted EBITDA margins by holding or raising price in most countries and by aggressively managing costs in response to the demand decline. NPI sales were down 2 percent, while our branded diamides were down by 7 percent, outperforming the rest of our portfolio and the broader market. The resilient performance of these differentiated products illustrates the importance of innovation in our business," Douglas said.
On a GAAP basis, cash flow from operations was negative
Full Year 2024 Outlook2
Full-year 2024 revenue is forecasted to be in the range of
"Our outlook for this year largely relies on factors within our control. We are viewing 2024 as a transition year, with momentum expected to build as the year progresses, driven by our new technologies and the benefits of our restructuring actions along with an improving demand backdrop. The structural actions we are taking now combined with the transitory nature of the majority of the cost headwinds should provide a strong setup for us to achieve our mid-term goals, including our unchanged 2026 financial projections." said Douglas.
First Quarter Outlook2
First quarter revenue is expected to be in the range of
Full Year 2024 Outlook2 | Q1 2024 Outlook2 | |
Revenue | ||
Growth at midpoint vs. 2023* | 2.5 % | -26 % |
Adjusted EBITDA | ||
Growth at midpoint vs. 2023* | 0 % | -59 % |
Adjusted EPS^ | ||
Growth at midpoint vs. 2023* | 1 % | -82 % |
^Adjusted EPS estimates assume 125.5 million diluted shares for full year and 125.5 million diluted shares for Q1. Outlook for Adjusted EPS and WADSO does not include the impact of any share repurchases that may take place in 2024. |
*Percentages are calculated using whole numbers. Minor differences may exist due to rounding. |
Supplemental Information
The company will post supplemental information on the web at https://investors.fmc.com, including its webcast slides for tomorrow's earnings call, definitions of non-GAAP terms and reconciliations of non-GAAP figures to the nearest available GAAP term.
Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions. FMC, the FMC logo and Premio Star are trademarks of FMC Corporation or an affiliate.
About FMC
FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers, crop advisers and turf and pest management professionals to address their toughest challenges economically while protecting the environment. With approximately 6,600 employees at more than 100 sites worldwide, FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn®.
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: FMC and its representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, in FMC's other filings with the SEC, and in presentations, reports or letters to FMC stockholders.
In some cases, FMC has identified these forward-looking statements by such words or phrases as "outlook", "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022 (the "2022 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2022 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ("SEC"). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement.
We specifically decline to undertake any obligation, and specifically disclaims any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.
This press release contains certain "non-GAAP financial terms" which are defined on our website www.fmc.com/investors. Such terms include adjusted EBITDA, adjusted earnings, free cash flow and organic revenue growth. In addition, we have also provided on our website reconciliations of non-GAAP terms to the most directly comparable GAAP term.
- Organic revenue growth (non-GAAP) excludes the impact of foreign currency changes.
- Although we provide forecasts for adjusted earnings per share, adjusted EBITDA, and free cash flow (non-GAAP financial measures), we are not able to forecast the most directly comparable measures calculated and presented in accordance with GAAP. Certain elements of the composition of the GAAP amounts are not predictable, making it impractical for us to forecast. Such elements include, but are not limited to, restructuring, acquisition charges, and discontinued operations. As a result, no GAAP outlook is provided.
FMC CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Unaudited) | |||||||
Three Months Ended | Twelve Months Ended | ||||||
December 31, | December 31, | ||||||
(In millions, except per share amounts) | 2023 | 2022 | 2023 | 2022 | |||
Revenue | $ 1,146.1 | $ 1,622.0 | $ 4,486.8 | $ 5,802.3 | |||
Costs of sales and services | 710.4 | 936.4 | 2,655.8 | 3,475.5 | |||
Gross margin | $ 435.7 | $ 685.6 | $ 1,831.0 | $ 2,326.8 | |||
Selling, general and administrative expenses | $ 171.5 | $ 212.5 | $ 734.3 | $ 775.2 | |||
Research and development expenses | 81.8 | 84.4 | 328.8 | 314.2 | |||
Restructuring and other charges (income) | 164.3 | (5.8) | 212.3 | 93.1 | |||
Total costs and expenses | $ 1,128.0 | $ 1,227.5 | $ 3,931.2 | $ 4,658.0 | |||
Income (loss) from continuing operations before non-operating | $ 18.1 | $ 394.5 | $ 555.6 | $ 1,144.3 | |||
Non-operating pension and postretirement charges (income) | 4.8 | 2.1 | 18.2 | 8.6 | |||
Interest expense, net | 56.7 | 44.8 | 237.2 | 151.8 | |||
Income (loss) from continuing operations before income taxes | $ (43.4) | $ 347.6 | $ 300.2 | $ 983.9 | |||
Provision (benefit) for income taxes | (1,197.0) | 12.2 | (1,119.3) | 145.2 | |||
Income (loss) from continuing operations | $ 1,153.6 | $ 335.4 | $ 1,419.5 | $ 838.7 | |||
Discontinued operations, net of income taxes | (57.2) | (55.0) | (98.5) | (97.2) | |||
Net income (loss) | $ 1,096.4 | $ 280.4 | $ 1,321.0 | $ 741.5 | |||
Less: Net income (loss) attributable to noncontrolling interests | (2.1) | 6.5 | (0.5) | 5.0 | |||
Net income (loss) attributable to FMC stockholders | $ 1,098.5 | $ 273.9 | $ 1,321.5 | $ 736.5 | |||
Amounts attributable to FMC stockholders: | |||||||
Income (loss) from continuing operations, net of tax | $ 1,155.7 | $ 328.9 | $ 1,420.0 | $ 833.7 | |||
Discontinued operations, net of tax | (57.2) | (55.0) | (98.5) | (97.2) | |||
Net income (loss) | $ 1,098.5 | $ 273.9 | $ 1,321.5 | $ 736.5 | |||
Basic earnings (loss) per common share attributable to FMC | |||||||
Continuing operations | $ 9.23 | $ 2.61 | $ 11.34 | $ 6.60 | |||
Discontinued operations | (0.46) | (0.44) | (0.79) | (0.77) | |||
Basic earnings per common share | $ 8.77 | $ 2.17 | $ 10.55 | $ 5.83 | |||
Average number of shares outstanding used in basic earnings per | 124.9 | 125.6 | 125.1 | 126.0 | |||
Diluted earnings (loss) per common share attributable to FMC | |||||||
Continuing operations | $ 9.23 | $ 2.61 | $ 11.31 | $ 6.58 | |||
Discontinued operations | (0.46) | (0.44) | (0.78) | (0.77) | |||
Diluted earnings per common share | $ 8.77 | $ 2.17 | $ 10.53 | $ 5.81 | |||
Average number of shares outstanding used in diluted earnings per | 125.2 | 126.4 | 125.5 | 126.7 | |||
Other Data: | |||||||
Capital additions and other investing activities | $ 27.1 | $ 16.0 | $ 143.7 | $ 118.7 | |||
Depreciation and amortization expense | 45.9 | 42.8 | 184.3 | 169.4 |
FMC CORPORATION RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO FMC STOCKHOLDERS (GAAP) TO ADJUSTED AFTER-TAX EARNINGS FROM CONTINUING OPERATIONS, ATTRIBUTABLE TO FMC STOCKHOLDERS (NON-GAAP) (Unaudited) | |||||||
Three Months Ended | Twelve Months Ended | ||||||
December 31, | December 31, | ||||||
(In millions, except per share amounts) | 2023 | 2022 | 2023 | 2022 | |||
Net income (loss) attributable to FMC stockholders (GAAP) | $ 1,098.5 | $ 273.9 | $ 1,321.5 | $ 736.5 | |||
Corporate special charges (income): | |||||||
Restructuring and other charges (income) (a) | 190.1 | (5.8) | 238.1 | 93.1 | |||
Non-operating pension and postretirement charges (income) (b) | 4.8 | 2.1 | 18.2 | 8.6 | |||
Income tax expense (benefit) on Corporate special charges (income) (c) | (24.3) | 4.3 | (32.8) | 1.5 | |||
Adjustment for noncontrolling interest, net of tax on Corporate special charges (income) | — | 6.8 | (1.6) | 6.8 | |||
Discontinued operations attributable to FMC stockholders, net of income taxes (d) | 57.2 | 55.0 | 98.5 | 97.2 | |||
Tax adjustment (e) | (1,192.9) | (37.3) | (1,167.4) | (5.3) | |||
Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP) (1) | $ 133.4 | $ 299.0 | $ 474.5 | $ 938.4 | |||
Diluted earnings per common share (GAAP) | $ 8.77 | $ 2.17 | $ 10.53 | $ 5.81 | |||
Corporate special charges (income) per diluted share, before tax: | |||||||
Restructuring and other charges (income) | 1.52 | (0.04) | 1.90 | 0.74 | |||
Non-operating pension and postretirement charges (income) | 0.04 | 0.02 | 0.15 | 0.07 | |||
Income tax expense (benefit) on Corporate special charges (income), per diluted share | (0.19) | 0.03 | (0.26) | 0.01 | |||
Adjustment for noncontrolling interest, net of tax on Corporate special charges (income) per diluted share | — | 0.05 | (0.02) | 0.05 | |||
Discontinued operations attributable to FMC stockholders, net of income taxes per diluted share | 0.46 | 0.44 | 0.78 | 0.77 | |||
Tax adjustments per diluted share | (9.53) | (0.30) | (9.30) | (0.04) | |||
Diluted adjusted after-tax earnings from continuing operations per share, attributable to FMC stockholders (Non-GAAP) | $ 1.07 | $ 2.37 | $ 3.78 | $ 7.41 | |||
Average number of shares outstanding used in diluted adjusted after-tax earnings from continuing operations per share computations | 125.2 | 126.4 | 125.5 | 126.7 |
____________________ | |
(1) | Referred to as Adjusted earnings. The Company believes that Adjusted earnings, a Non-GAAP financial measure, and its presentation on a per share basis, provides useful information about the Company's operating results to management, investors, and securities analysts. Adjusted earnings excludes the effects of Corporate special charges, tax-related adjustments and the results of our discontinued operations. The Company also believes that excluding the effects of these items from operating results allows management and investors to compare more easily the financial performance of its underlying businesses from period to period. |
(a) | Three Months Ended December 31, 2023: |
Restructuring and other charges (income) includes | |
Three Months Ended December 31, 2022: | |
Restructuring and other charges (income) includes | |
Twelve Months Ended December 31, 2023: | |
Restructuring and other charges (income) includes | |
Twelve Months Ended December 31, 2022: | |
Restructuring and other charges (income) is primarily comprised of | |
(b) | Our non-operating pension and postretirement charges (income) are defined as those costs (benefits) related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These are excluded from our Adjusted Earnings and are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We continue to include the service cost and amortization of prior service cost in our Adjusted Earnings results noted above. These elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. |
(c) | The income tax expense (benefit) on Corporate special charges (income) is determined using the applicable rates in the taxing jurisdictions in which the Corporate special charge or income occurred and includes both current and deferred income tax expense (benefit) based on the nature of the non-GAAP performance measure. |
(d) | Discontinued operations for all periods presented includes provisions, net of recoveries, for environmental liabilities and legal reserves and expenses related to previously discontinued operations and retained liabilities. |
(e) | We exclude the GAAP tax provision, including discrete items, from the Non-GAAP measure of income, and include a Non-GAAP tax provision based upon the annual Non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but not limited to: income tax expenses or benefits that are not related to continuing operating results in the current year; unusual or infrequently occurring items; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; certain changes in the realizability of deferred tax assets; and changes in tax law. Management believes excluding these discrete tax items assists investors and securities analysts in understanding the tax provision and the effective tax rate related to continuing operations thereby providing investors with useful supplemental information about FMC's operational performance. |
Three Months Ended | Twelve Months Ended | ||||||||||
December 31, | December 31, | ||||||||||
(In millions) | 2023 | 2022 | 2023 | 2022 | |||||||
Tax adjustments: | |||||||||||
Impacts of valuation allowances of deferred tax assets | 95.0 | 1.8 | 95.0 | 1.8 | |||||||
Foreign currency remeasurement and other discrete items | (1,287.9) | (39.1) | (1,262.4) | (7.1) | |||||||
Total Non-GAAP tax adjustments | $ (1,192.9) | $ (37.3) | $ (1,167.4) | $ (5.3) |
During the three months ended December 31, 2023, the Company's Swiss subsidiaries were granted ten-year tax incentives effective for 2023 and retroactively for 2021 and 2022. The tax incentives were awarded for the Company's commitment to invest in additional headcount and transfer significant intellectual property, which is planned for 2024, as well as establishing a new global technology and innovation center in |
Historically, FMC's |
RECONCILIATION OF NET INCOME (LOSS) (GAAP) TO ADJUSTED EARNINGS FROM CONTINUING OPERATIONS, BEFORE INTEREST AND INCOME TAXES, DEPRECIATION AND AMORTIZATION, AND NONCONTROLLING INTERESTS (NON-GAAP) (Unaudited) | |||||||
Three Months Ended | Twelve Months Ended | ||||||
December 31, | December 31, | ||||||
(In millions) | 2023 | 2022 | 2023 | 2022 | |||
Net income (loss) (GAAP) | $ 1,096.4 | $ 280.4 | $ 1,321.0 | $ 741.5 | |||
Restructuring and other charges (income) (2) | 190.1 | (5.8) | 238.1 | 93.1 | |||
Non-operating pension and postretirement charges (income) | 4.8 | 2.1 | 18.2 | 8.6 | |||
Discontinued operations, net of income taxes | 57.2 | 55.0 | 98.5 | 97.2 | |||
Interest expense, net | 56.7 | 44.8 | 237.2 | 151.8 | |||
Depreciation and amortization | 45.9 | 42.8 | 184.3 | 169.4 | |||
Provision (benefit) for income taxes | (1,197.0) | 12.2 | (1,119.3) | 145.2 | |||
Adjusted earnings from continuing operations, before interest, | $ 254.1 | $ 431.5 | $ 978.0 | $ 1,406.8 |
___________________ | |
(1) | Referred to as Adjusted EBITDA. Defined as operating profit excluding corporate special charges (income) and depreciation and amortization expense. |
(2) | Includes |
RECONCILIATION OF CASH PROVIDED (REQUIRED) BY OPERATING ACTIVITIES (GAAP) TO FREE CASH FLOW (NON-GAAP) (Unaudited) | |||||||
Three Months Ended | Twelve Months Ended | ||||||
December 31, | December 31, | ||||||
(In millions) | 2023 | 2022 | 2023 | 2022 | |||
Cash provided (required) by operating activities of continuing operations (GAAP) (1) | $ 317.9 | $ 644.3 | $ (300.3) | $ 660.0 | |||
Transaction and integration costs | — | — | — | 0.5 | |||
Adjusted cash from operations (2) | $ 317.9 | $ 644.3 | $ (300.3) | $ 660.5 | |||
Capital expenditures | $ (25.1) | $ (33.9) | $ (133.9) | $ (142.3) | |||
Other investing activities | (2.0) | 17.9 | (9.8) | 23.6 | |||
Capital additions and other investing activities | $ (27.1) | $ (16.0) | $ (143.7) | $ (118.7) | |||
Cash provided (required) by operating activities of discontinued operations | $ (25.1) | $ (25.8) | $ (86.1) | $ (77.6) | |||
Transaction and integration costs | — | — | — | (0.5) | |||
Proceeds from land disposition (3) | — | 50.5 | 5.8 | 50.5 | |||
Legacy and transformation | $ (25.1) | $ 24.7 | $ (80.3) | $ (27.6) | |||
Free cash flow (Non-GAAP) (4) | $ 265.7 | $ 653.0 | $ (524.3) | $ 514.2 |
___________________ | |
(1) | The cash provided (required) by operating activities for the three months ended December 31, 2023 and 2022 is the calculation of the twelve months ended December 31, 2023 and 2022 less the previously reported nine months ended September 30, 2023 and 2022, respectively. |
(2) | Adjusted cash from operations is defined as cash provided (required) by operating activities of continuing operations excluding the effects of transaction-related cash flows. |
(3) | Amounts for the year ended December 31, 2023 and 2022 include proceeds of |
(4) | Free cash flow is defined as Adjusted cash from operations reduced by spending for capital additions and other investing activities as well as legacy and transformation spending. We believe that this Non-GAAP financial measure provides a useful basis for investors and securities analysts about the cash generated by routine business operations, including capital expenditures, in addition to assessing our ability to repay debt, fund acquisitions and return capital to shareholders through share repurchases and dividends. Our use of free cash flow has limitations as an analytical tool and should not be considered in isolation or as a substitute for an analysis of our results under |
RECONCILIATION OF REVENUE CHANGE (GAAP) TO ORGANIC REVENUE CHANGE (NON-GAAP) (1) (Unaudited) | |||
Three Months Ended | Twelve Months Ended | ||
Total Revenue Change (GAAP) | (29) % | (23) % | |
Less: Foreign Currency Impact | 1 % | (1) % | |
Organic Revenue Change (Non-GAAP) | (30) % | (22) % |
___________________ | |
(1) | We believe organic revenue growth (non-GAAP) provides management and investors with useful supplemental information regarding our ongoing revenue performance and trends by presenting revenue growth excluding the impact of fluctuations in foreign exchange rates. |
RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO FMC STOCKHOLDERS (GAAP) TO RETURN ON INVESTED CAPITAL ("ROIC") NUMERATOR (NON-GAAP) AND ROIC (USING NON-GAAP NUMERATOR)(1) (Unaudited) | |||
Twelve Months Ended | |||
December 31, 2023 | |||
Net income (loss) attributable to FMC stockholders (GAAP) | $ 1,321.5 | ||
Interest expense, net, net of income taxes | 202.8 | ||
Corporate special charges (income) | 256.3 | ||
Income tax expense (benefit) on Corporate special charges (income) | (32.8) | ||
Adjustment for noncontrolling interest, net of tax on Corporate special charges (income) | (1.6) | ||
Discontinued operations attributable to FMC stockholders, net of income taxes | 98.5 | ||
Tax adjustments | (1,167.4) | ||
ROIC numerator (Non-GAAP) | 677.3 | ||
December 31, 2023 | December 31, 2022 | ||
Total debt | 3,957.6 | 3,274.0 | |
Total FMC stockholders' equity | 4,410.9 | 3,377.9 | |
Total debt and FMC stockholders' equity (GAAP) | 8,368.5 | 6,651.9 | |
ROIC denominator (2 yr average total debt and FMC stockholders' equity) | 7,510.2 | ||
ROIC (using Non-GAAP numerator) | 9.02 % |
___________________ | |
(1) | We believe ROIC provides management and investors with useful supplemental information regarding our utilization of capital provided by both equity and debt as well as our working capital and free cash flow management. |
FMC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
| |||
(In millions) | December 31, 2023 | December 31, 2022 | |
Cash and cash equivalents | $ 302.4 | $ 572.0 | |
Trade receivables, net of allowance of | 2,703.2 | 2,871.4 | |
Inventories | 1,724.6 | 1,651.6 | |
Prepaid and other current assets | 398.9 | 343.6 | |
Total current assets | $ 5,129.1 | $ 5,438.6 | |
Property, plant and equipment, net | 892.5 | 849.6 | |
Goodwill | 1,593.6 | 1,589.3 | |
Other intangibles, net | 2,465.1 | 2,508.1 | |
Deferred income taxes | 1,336.6 | 210.7 | |
Other long-term assets | 509.3 | 575.0 | |
Total assets | $ 11,926.2 | $ 11,171.3 | |
Short-term debt and current portion of long-term debt | $ 934.0 | $ 540.8 | |
Accounts payable, trade and other | 602.4 | 1,252.2 | |
Advanced payments from customers | 482.1 | 680.5 | |
Accrued and other liabilities | 684.8 | 601.8 | |
Accrued customer rebates | 480.9 | 465.3 | |
Guarantees of vendor financing | 69.6 | 142.0 | |
Accrued pensions and other postretirement benefits, current | 6.4 | 2.3 | |
Income taxes | 124.4 | 114.7 | |
Total current liabilities | $ 3,384.6 | $ 3,799.6 | |
Long-term debt, less current portion | $ 3,023.6 | $ 2,733.2 | |
Long-term liabilities | 1,084.6 | 1,237.6 | |
Equity | 4,433.4 | 3,400.9 | |
Total liabilities and equity | $ 11,926.2 | $ 11,171.3 |
FMC CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) | |||
Year Ended December 31, | |||
(In millions) | 2023 | 2022 | |
Cash provided (required) by operating activities of continuing operations | $ (300.3) | $ 660.0 | |
Cash provided (required) by operating activities of discontinued operations | (86.1) | (77.6) | |
Cash provided (required) by investing activities of continuing operations | (154.4) | (266.4) | |
Cash provided (required) by financing activities of continuing operations | 331.5 | (237.4) | |
Effect of exchange rate changes on cash | (60.3) | (23.4) | |
Increase (decrease) in cash and cash equivalents | $ (269.6) | $ 55.2 | |
Cash and cash equivalents, beginning of period | 572.0 | 516.8 | |
Cash and cash equivalents, end of period | $ 302.4 | $ 572.0 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/fmc-corporation-announces-fourth-quarter-and-full-year-2023-results-within-guidance-ranges-provides-2024-outlook-302053725.html
SOURCE FMC Corporation
FAQ
What was FMC Corporation's revenue in Q4 2023?
What was the change in FMC Corporation's full-year 2023 revenue?
What was the outlook for FMC Corporation's full-year 2024 revenue?
What was the change in FMC Corporation's adjusted EBITDA in Q4 2023?